ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DPH Dechra Pharmaceuticals Plc

3,866.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dechra Pharmaceuticals Plc LSE:DPH London Ordinary Share GB0009633180 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3,866.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Dechra Pharmaceuticals PLC Result of AGM - 20 October 2017 (2365U)

20/10/2017 2:35pm

UK Regulatory


Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Dechra Pharmaceuticals Charts.

TIDMDPH

RNS Number : 2365U

Dechra Pharmaceuticals PLC

20 October 2017

Date: 20 October 2017

Dechra(R) Pharmaceuticals PLC

Results of Annual General Meeting (AGM)

AGM Meeting Date: 1pm on 20 October 2017

Issued Share Capital at meeting date: 93,415,750

Number of shareholders in attendance: 12

All resolutions were passed on a show of hands.

Details of the proxy voting instructions lodged prior to the AGM are set out below:

 
 Resolution (No.                         Total For            Total Against       Withheld 
  as noted on proxy                       (1)                                      (2) 
  form) 
--------------------------------------  -------------------  ------------------  ---------- 
                                         No. of       %       No. of      %       No. of 
                                          votes        of      votes       of      votes 
                                                       vote                vote 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 1: 
  To receive the 
  accounts, the Strategic 
  Report, the Directors' 
  Report and the 
  Auditor's Report                       69,787,352   94.83   3,801,367   5.17      176,986 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 2: 
  To receive and 
  approve the Directors' 
  Remuneration Report                    66,111,495   94.18   4,086,647   5.82    3,567,713 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 3: 
  To receive and 
  approve the Directors' 
  Remuneration Policy                    72,932,631   98.88     823,955   1.12        8,619 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 4: 
  To declare a final 
  dividend                               73,764,546   100             0   0.00          659 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 5: 
  To elect Richard 
  Cotton                                 72,195,608   97.87   1,568,938   2.13          659 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 6: 
  To elect Lawson 
  Macartney                              73,401,877   99.51     361,469   0.49        1,859 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 7: 
  To re-elect Tony 
  Rice                                   66,992,715   92.48   5,448,270   7.52    1,324,220 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 8: 
  To re-elect Ian 
  Page                                   72,285,663   98.00   1,478,883   2.00          659 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 9: 
  To re-elect Anthony 
  Griffin                                72,279,341   97.99   1,485,205   2.01          659 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 10: 
  To re-elect Julian 
  Heslop                                 73,500,858   99.64     263,688   0.36          659 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 11: 
  To re-elect Ishbel 
  Macpherson                             73,144,501   99.16     620,045   0.84          659 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 12: 
  To reappoint PricewaterhouseCoopers 
  as external auditor 
  of the Company                         73,756,778   99.99       7,318   0.01        1,109 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 13: 
  To authorise the 
  Audit Committee 
  to determine the 
  remuneration of 
  the external auditor                   73,763,069   100         1,027   0.00        1,109 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 14: 
  To authorise the 
  Directors to allot 
  shares to specific 
  limits                                 69,568,791   94.32   4,191,805   5.68        4,609 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 15: 
  To disapply the 
  pre-emption rights                     72,858,327   98.78     903,219   1.22        3,659 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 16: 
  To disapply additional 
  pre-emption rights                     67,395,228   91.37   6,366,318   8.63        3,659 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 17: 
  To authorise the 
  Company to purchase 
  its own shares                         72,978,224   99.07     685,466   0.93      101,515 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 Resolution 18: 
  To call general 
  meetings (other 
  than an AGM) on 
  not less than 14 
  clear days' notice                     71,828,591   97.38   1,935,505   2.62        1,109 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
      Resolution 19: 
       (a) To approve 
       the rules of the 
       LTIP 2017; and 
       (b) To authorise 
       the Directors to 
       adopt further schemes 
       based on the LTIP 
       2017                              70,433,043   95.49   3,328,963   4.51        3,199 
--------------------------------------  -----------  ------  ----------  ------  ---------- 
 

Notes

   1.   Includes discretionary votes. 

2. A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.

3. Resolutions 1 to 14 and Resolution 19 were ordinary resolutions, requiring more than 50% of shareholder votes to be "for" the resolutions.

4. Resolutions 15 to 18 were special resolutions, requiring more than 75% of shareholder votes to be "for" the resolutions.

5. Votes tendered in respect of 73,765,205 shares representing 78.96% of the issued share capital.

In accordance with Listing Rule 9.6.2R, a copy of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

For further information

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. The majority of Dechra's products are focused on key therapeutic categories where we have leading market positions, and many of our products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information, please visit: www.dechra.com.

Trademarks

Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGFMMZGFGDGNZM

(END) Dow Jones Newswires

October 20, 2017 09:35 ET (13:35 GMT)

1 Year Dechra Pharmaceuticals Chart

1 Year Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock